National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

NY-ESO-1 peptide vaccine
A cancer vaccine consisting of an immunogenic peptide derived from the cancer-testis antigen (NY-ESO-1), an antigen found in normal testis and various tumors. Vaccination with NY-ESO-1 peptide vaccine may stimulate the host immune system to mount a humoral and cytotoxic T lymphocyte (CTL) response to cells expressing NY-ESO-1 antigen, resulting in tumor cell lysis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:ESO-1 Peptide Vaccine



Previous:Nplate, nucleotide analogue GS 9219, Nutracort, NutreStore, Nuvion
Next:NY-ESO-1 plasmid DNA cancer vaccine, NY-ESO-1/LAGE-1 HLA class I/II peptide vaccine, NY-ESO-1b peptide vaccine, NY-ESO-B, O6-benzylguanine

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov